Renal Transplant Injury and the Renin-Angiotensin System in Kids (RETASK)
Completed
Conditions studied: Renal Transplant, Renin-Angiotensin System, Rejection Acute Renal, Rejection Chronic Renal, Rejection of Renal Transplant
In brief
In pediatric kidney transplant patients, rejection, medication toxicity and ischemia cause early and chronic renal allograft injury, which reduces graft lifespan and patient survival. Early detection of injury would facilitate prevention and treatment. The gold standard surveillance biopsy has limitations including delayed discovery of injury. No noninvasive test identifies graft injury before it is clinically apparent. This project's goal is to develop a novel early marker of subclinical graft injury to facilitate prompt recognition and treatment.
Key facts
- Study ID
- NCT03317925
- Run by
- Wake Forest University Health Sciences
- People needed
- 29
- Starts
- 2014-07-16
- Expected to finish
- 2017-04-26
- Last updated by the study team
- 2017-11-08
Who can join
Age: 1 and older, up to 20. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Ages 1 - 20 years
- Actively listed on the transplant list at Lucile Packard Children's Hospital at Stanford and received a renal transplant during the study enrollment period
You may not qualify if…
- Transplanted at a center other than Lucile Packard Children's Hospital at Stanford
Where it is running
- Wake Forest University Baptist Medical Center — Winston-Salem, North Carolina, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.